The oral intake of specific Bioactive Collagen Peptides (BCP) improves gait and quality of life in canine osteoarthritis patients-A translational large animal model for a nutritional therapy option.
Britta DobeneckerLinda Franziska BöswaldSven ReeseStephanie Steigmeier-RaithLukas TrilligSteffen OesserMichael SchunckAndrea Meyer-LindenbergJutta HugenbergPublished in: PloS one (2024)
The results of this three-month BCP supplementation study using objective measurement parameters in dogs with naturally occurring OA demonstrate an efficacy, suggesting the therapeutic use of BCP in canine OA patients and demonstrating the relevance of this collagen hydrolysate formulation for the treatment of OA in human patients as well.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- stem cells
- rheumatoid arthritis
- endothelial cells
- drug delivery
- body mass index
- mesenchymal stem cells
- patient reported outcomes
- physical activity
- bone marrow
- weight loss
- induced pluripotent stem cells
- amino acid
- wound healing